Skip to main content
Clinical Trials/CTRI/2022/08/044700
CTRI/2022/08/044700
Not Yet Recruiting
Phase 4

Randomized placebo controlled single blind study of the effectiveness of ACOTIAMIDE in functional dyspepsia

Payel Chakraborty0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Payel Chakraborty
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Payel Chakraborty

Eligibility Criteria

Inclusion Criteria

  • 1\)No upper GI abnormality in upper GI endoscopy
  • 2\)Symptoms of dyspepsia for atleast 1 month

Exclusion Criteria

  • 1\.Patient with abnormal upper GI endoscopy.
  • 2\. Patient with alarm features (unintentional weight loss, persistent vomiting, dysphagia, hematemesis, melena, fever,
  • jaundice, or anemia),
  • 3\. Recent gastrointestinal surgery i.e. within 30 days.
  • 4\. Patients who show any of the following values at the baseline laboratory tests: severe anaemia, total leukocyte count \<
  • , platelet count \< 75,000/mm3
  • , AST and ALT ââ?°Â¥ 100 IU/L, Creatinine ââ?°Â¥ 1\.5 mg/dL The blood tests should
  • have been done not more than 4 weeks prior to enrollment.
  • 5\.Treatment with non\-steroidal anti\-inflammatory drugs (NSAIDs), H2\-blockers, proton pump inhibitors, prokinetic
  • agents, misoprostol or sucralfate 15 days prior to enrollment.

Outcomes

Primary Outcomes

Not specified

Similar Trials